SUBSCRIBE
SUBSCRIBE

Panbela Therapeutics Inc.

IN THE PRESS
Business
Sun BioPharma, Inc. Initiates Search for CEOCompany founder Dr. Michael T. Cullen intends to continue to serve as Executive Chairman and will continue to serve as President and CEO until a successor is named
January 28, 2020
 · 
4 min read
Drug Development
Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
January 24, 2020
 · 
7 min read
Drug Development
Sun BioPharma, Inc. Announces Data Presentation at the ASCO 2020 Annual Gastrointestinal Cancers SymposiumBiotech Executive Arthur Fratamico Recently Joined Board of Directors
December 23, 2019
 · 
6 min read
Business
Sun BioPharma, Inc. Provides a Business Update and Reports Q3 2019 Financial Results
November 13, 2019
 · 
12 min read
BioMidwest
Sun Biopharma Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer
January 29, 2018
 · 
5 min read
Business
Sun BioPharma Files Form 10-Q for Third Quarter 2017 and Provides Business Update
November 14, 2017
 · 
15 min read
BioMidwest
Sun BioPharma Announces Execution of Reverse Stock Split
November 8, 2017
 · 
5 min read
Drug Development
Sun BioPharma Achieves Significant Milestone With Successful Completion Of Patient Enrollment In Phase Ia Dose Escalation Safety Study Of SBP-101 For Patients With Pancreatic Cancer
October 4, 2017
 · 
6 min read
Drug Development
Sun BioPharma Files Form 10-Q For Second Quarter 2017 And Provides Clinical Update
August 10, 2017
 · 
1 min read
Drug Development
Sun BioPharma Announces Completion Of The Fifth Patient Cohort In The Dose Escalation Phase Ia Study Of SBP-101 For Pancreatic Cancer
June 7, 2017
 · 
6 min read
Load More
JOBS